Biopharma’s Dark Data Problem

Pharmaceutical R&D is a long, arduous and expensive process. And in many cases the years of research, testing and funding end in unsuccessful outcomes. In fact, the Pharmaceutical Research and Manufacturers of America reports that only 1 in 5,000 drug candidates result in a commercial product with a median capitalized research and development cost per product of $985 million as reported by The Journal of the American Medical Association (JAMA).

That’s a lot of time and money, but it’s not stopping pharmaceutical companies from investing in drug discovery. According to Statista, worldwide spending on pharmaceutical R&D will reach $230 billion by 2026.

So with investment dollars flowing in and R&D continuing...